Earlier immunomodulatory treatment is associated with better visual outcomes in a subset of patients with <scp>V</scp>ogt‐<scp>K</scp>oyanagi‐<scp>H</scp>arada disease

Abstract

There were no differences in outcomes between first-line IMT and prednisone alone/late IMT in the entire VKH group. However, in a subset of patients, there was a significant better functional outcome with earlier IMT initiation.